HealthFlex
×
  • Home
  • Immunology Book
  • Lab Tests
    • Hematology
    • Fluid analysis
    • CSF
    • Urine Analysis
    • Chemical pathology
    • Blood banking
    • Fungi
    • General pathology
    • Immune system
    • Microbiology
    • Parasitology
    • Pathology
    • Tumor marker
    • Virology
    • Cytology
  • Lectures
    • Bacteriology
    • Liver
    • Lymph node
    • Mycology
    • Virology
  • Blog
    • Economics and technical
    • Fitness health
    • Mental health
    • Nutrition
    • Travel
    • Preventive health
    • Nature and photos
    • General topic
  • Medical Dictionary
  • About Us
  • Contact

Prothrombin Time (PT)

March 3, 2023HematologyLab Tests

Table of Contents

  • Prothrombin Time (PT)
      • Sample for Prothrombin Time (PT)
      • Precautions for Prothrombin Time (PT)
      • Indications for Prothrombin Time (PT)
      • Pathophysiology of Prothrombin Time (PT)
      • Prothrombin facts:
      • Principle of prothrombin time (PT):
    • Clotting Mechanism
      • NORMAL Prothrombin Time (PT)
      • Increased Prothrombin Time (PT) is seen in the following:
      • Summary of Prothrombin Time (PT) and  Partial thromboplastin time (PTT):
      • Questions and answers:

Prothrombin Time (PT)

Sample for Prothrombin Time (PT)

  • The blood sample is taken with ESR (sodium citrate) solution.
    • The blood sample is 1.8 ml, and the ESR solution is 0.2 ml.
Prothrombin test (PT): Sample for Prothrombin test (PT)

Prothrombin test (PT): Sample for Prothrombin test (PT)

Precautions for Prothrombin Time (PT)

  1. Alcohol intake can increase PT time.
  2. A high-fat diet may decrease PT time.
  3. Some drugs decrease PT, like anabolic steroids, digitalis, Benadryl, griseofulvin, oral contraceptives, vitamin K, and chloral hydrate.
  4. Some drugs can increase PT, like aminosalicylic acid, barbiturates, beta-lactam antibiotics, chloramphenicol, clofibrate, heparin, methyldopa, neomycin, quinidine, quinine, sulphonamides, and salicylates.

Indications for Prothrombin Time (PT)

  1. This is one of the screening tests for coagulation.
  2. This test evaluates the extrinsic pathway defect.
  3. This test also finds a common pathway defect.
  4. This test is done For the screening of prothrombin deficiency.
  5. PT is also used to evaluate dysfibrinogenemia.
  6. PT is done to monitor the heparin and coumarin effect.
  7. In the case of bruises and abnormal bleeding.
  8. In the case of Vit. K deficiency.
  9. This is advised as a liver function test.
    1. This is used to assess synthetic liver function.
  10. To monitor the Warfarin therapy.

Pathophysiology of Prothrombin Time (PT)

  1. Prothrombin is a protein produced by the liver. Its molecular weight is 71,600 Daltons.
    1. Prothrombin helps in the clotting mechanism.
    2. Prothrombin production depends upon the adequate intake amount of Vit. K and its absorption.
    3. It is the most abundant and has a long half-life of the vit. K dependant clotting proteins circulate as a zymogen to serine protease.
  2. On clotting, prothrombin is converted into thrombin.
    1. Prothrombin   Thrombin.
Prothrombin and its function

Prothrombin and its function

Clotting mechanism and role prothrombin

Clotting mechanism and role prothrombin

  1. Factor II, VII, IX, and X depend upon the Vit. K for biosynthesis.

Prothrombin facts:

  1. The abnormality in prolonged Prothrombin test (PT):
    1. Factors I, II, VII, and X deficiency.
    2. Warfarin, liver diseases, and it. K deficiency.
  2. Prothrombin Time (PT) measures :
    1. Extrinsic pathway (Activated VIIa)
    2. Tissue factor.
    3. Common pathways ( factor X, V, II, and fibrinogen ).

Principle of prothrombin time (PT):

Prothrombin time (PT) reaction

Prothrombin time (PT) reaction

Clotting Mechanism

  1. The first stage is an aggregation of platelets to plug the damaged blood vessels.
  2. The second stage is by activation of clotting factors.
    1. The first phase of the activation of the intrinsic pathway.
    2. At the same time, the extrinsic pathway is activated.
    3. By common pathway, factor X is activated by the proteases formed by the intrinsic and extrinsic pathways.
    4. The fourth phase is the conversion of prothrombin to thrombin in the presence of Factor X, Factor V, phospholipids, and calcium.
    5. Thrombin converts fibrinogen to fibrin.
Mechanism of Coagulation hemostasis

Mechanism of Coagulation hemostasis

Role of prothrombin to form stable clot

Role of prothrombin to form a stable clot

  1. Fibrin is converted into a stable gel.
  2. XIII cross-links the fibrin and forms the clot.
Blood coagulation process: Coagulation pathways

Blood coagulation process: Coagulation pathways

NORMAL Prothrombin Time (PT)

  • PT = 11 to 13 seconds (normally PT is 85% to 100%)
    • (This may vary from lab to lab).
    • This should be compared with the control, which will be around 11 to 14 seconds.
    • Anticoagulant therapy response =  1.5 to 2 times the control value.
    • Critical value = >20 seconds
  • INR is an international normalized ratio. = 0.8 to 1.1

Increased Prothrombin Time (PT) is seen in the following:

  1. Deficiency of factor II (prothrombin), V, VII, and X.
  2. Liver diseases, like cirrhosis and hepatic failure.
    1. Factor I, II, V, VII, IX, and X are produced in the liver.
    2. This is abnormal when there is a severe disease of the liver.
  3. Biliary obstruction. There is a lack of bile which is needed for fat-soluble vitamins like Vit. A, D, E, and K for their absorption.
    1. Synthesis of factors II, VII, and X depends upon the vitamin K.
    2. Suppose the patients respond to Vit. K therapy in 1 to 3 days means no liver cell damage; rather, there is a biliary obstruction.
    3. If there is no response to Vit. k therapy, the patient has severe liver cell injury.
  4. Sprue, celiac disease, and chronic diarrhea.
  5. Vit. K deficiency, even in the newborn of the mother with Vit. K deficiency.
  6. Hemorrhagic disease of the newborn.
  7. Anticoagulant therapy (Warfarin and Coumadin).
  8. D I C.
  9. Factor 1 deficiency (Hypofibrinogenemia).
  10. Dysfibrinogenemia.
  11. Circulating anticoagulants are seen in lupus disease.
  12. Premature newborn.
  13. Salicylates intoxication.
  14. Massive blood transfusion.

Summary of Prothrombin Time (PT) and  Partial thromboplastin time (PTT):

  1. Abnormal PTT alone
    1. Bleeding due to deficiency of factors V11, IX, and XI.
  2. Abnormal PT only
    1. Factor VII deficiency.
  3. Abnormal PT and PTT both
    1. Anticoagulant therapy.
    2. D I C.
    3. Vit. K deficiency.
    4. Liver diseases.
    5. Massive blood transfusion.
    6. Rarely due to Dysfibrinogenemia and deficiency of factors X, V, and II.
 Clinical condition Prothrombin time Thrombin time APTT Platelets count
Heparin therapy prolonged mild prolonged prolonged normal (the count is low)
Oral anticoagulants Prolonged normal prolonged normal
Circulating anticoagulant normal/prolonged normal prolonged normal
DIC prolonged prolonged prolonged low
Liver disease prolonged normal (rarely prolonged) prolonged low
Blood transfusion, massive prolonged normal prolonged low
Vit. K deficiency prolonged normal prolonged normal
  • Please, for more information, see PTT and APTT.

Questions and answers:

Question 1: What factor deficiency will be diagnosed by prothrombin time?
Show answer
Prothrombin time detects factor VII deficiency.
Question 2: What is the critical value of prothrombin time?
Show answer
Prothrombin time when it is >20 seconds.

Possible References Used
Go Back to Hematology

Add Comment Cancel



The reCAPTCHA verification period has expired. Please reload the page.

  • Lab Tests
    • Blood banking
    • Chemical pathology
    • CSF
    • Cytology
    • Fluid analysis
    • Fungi
    • General pathology
    • Hematology
    • Immune system
    • Microbiology
    • Parasitology
    • Pathology
    • Tumor marker
    • Urine Analysis
    • Virology

About Us

Labpedia.net is non-profit health information resource. All informations are useful for doctors, lab technicians, nurses, and paramedical staff. All the tests include details about the sampling, normal values, precautions, pathophysiology, and interpretation.

[email protected]

Quick Links

  • Blog
  • About Us
  • Contact
  • Disclaimer

Our Team

Professor Dr. Riaz Ahmad Bhutta

Dr. Naheed Afroz Syed

Dr. Asad Ahmad, M.D.

Dr. Shehpar Khan, M.D.

Copyright © 2014 - 2023. All Rights Reserved.
Web development by Farhan Ahmad.